Encapsulation of nucleic acids and opportunities for cancer treatment

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapy

Background:

• Nucleic acid drugs offer promising cancer treatment strategies.
• Efficient delivery of nucleic acid therapeutics to target cells is a major hurdle.
• Encapsulation technologies are crucial for overcoming delivery challenges.

Purpose of the Study:

• To provide a comprehensive review of encapsulation technologies for nucleic acid-based anti-cancer agents.
• To discuss micro and nanoparticle systems for delivering plasmid DNA and oligonucleotides.
• To highlight the potential of these delivery systems in cancer immunotherapy and direct tumor cell targeting.

Main Methods:

• Review of current literature on encapsulation technologies for nucleic acid delivery.
• Discussion of microparticle and nanoparticle systems.
• Analysis of applications in DNA immunotherapy and oligonucleotide-based therapies.

Main Results:

• Encapsulation in micro and nanoparticles is a viable strategy for nucleic acid drug delivery.
• Systems are being developed for both DNA immunotherapy and direct tumor cell targeting.
• Promising results indicate efficient delivery of therapeutic nucleic acids.

Conclusions:

• Encapsulation technologies are essential for advancing nucleic acid-based cancer therapies.
• Micro and nanoparticles show significant potential for targeted delivery of nucleic acids.
• Further development of these systems could lead to more effective cancer treatments.